| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | macrogol '3350'/sodium chloride/sodium hydrogen carbonate/potassium chloride (CosmoCol® paediatric 6.9g) |
| Formulation | 6.9 g powder for oral solution |
| Reference number | 2574 |
| Indication | Treatment of chronic constipation in children aged 2 – 11 years and treatment of faecal impaction in children aged 5 years and above. Faecal impaction is defined as refractory constipation with faecal loading in the rectum and/or colon |
| Company | Stirling Anglian Pharmaceuticals Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 22/09/2014 |